Reuters logo
BRIEF-Abeona Therapeutics enrolls first two patients in phase 1/2 clinical trial in MPS IIIA
October 11, 2017 / 1:12 PM / 10 days ago

BRIEF-Abeona Therapeutics enrolls first two patients in phase 1/2 clinical trial in MPS IIIA

Oct 11 (Reuters) - Abeona Therapeutics Inc:

* Abeona Therapeutics enrolls first two patients in pivotal expansion of phase 1/2 clinical trial in MPS IIIA

* Says to ‍report additional clinical data in ABO-102 global trial later this year​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below